Pharma Industry News

AbbVie hikes 2018 forecast and promises shareholder rewards, thanks to U.S. tax changes

Written by David Miller

The benefits of the upcoming tax overhaul will be so great that AbbVie is planning $2.5 billion in capital projects in the U.S., plus a pension and compensation boost for employees, it said during its fourth-quarter earnings release. But the company is also under pressure to return some of its growing cash haul to investors.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]